MKMaksim O. Karpechkin

Maksim O. Karpechkin

*This is an algorithmically generated author record based on publicly available information.

Maksim O. Karpechkin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Applications of indocyanine green in medicine

    by A. O. Nemechkina, D. V. Davydov, A. D. Zikiryakhodzhaev, V. O. Timoshkin, M. O. Karpechkin, А. О. Немечкина, Д. В. Давыдов, А. Д. Зикиряходжаев, В. О. Тимошкин, М. О. Карпечкин

    Purpose of the study . To analyze the literature on the use of indocyanine green in medicine. Materials and methods . A literature review was conducted using the PubMed, Google Scholar, and eLibrary databases, covering the period from 1995 to 2026. Results . Indocyanine green (ICG) is a water-soluble fluorescent dye developed in the mid‑20th century and approved for clinical use in the late 1950s. It is now widely used in various fields of medicine. In oncology, ICG is used for sentinel lymph node mapping to facilitate the detection of metastatic spread. In reconstructive and plastic surgery, intraoperative assessment with ICG reduces the risk of complications associated with autologous and implant-based reconstruction by enabling the identification of poorly perfused tissue and thereby reducing the incidence of tissue necrosis. In ophthalmology, ICG enables visualization and assessment of the fundus vasculature, particularly the choroidal circulation, in various ocular diseases. In cardiology and cardiac surgery, ICG is used to determine cardiac output and to assess anastomoses and coronary artery bypass grafts. In neurosurgery, ICG is used to visualize vascular structures, assess tissue perfusion and tumor margins, and assist in peripheral nerve reconstruction. In abdominal surgery, ICG facilitates assessment of anastomotic perfusion and visualization of tumor resection margins, thereby reducing the risk of postoperative complications, and may aid in the detection and differentiation of liver metastases. Conclusion . Indocyanine green is a versatile agent used for both intraoperative navigation and the assessment of surgical treatment outcomes. Advances in diagnostic and imaging technologies continue to create new opportunities for expanding the clinical applications of this method.

  • Open Access

    Effects of heterogeneous collagen-based formulation on growth and metastasis of B16-F1 melanoma in mice: an experimental, cohort, controlled study

    by Dmitry V. Davydov, Maksim O. Karpechkin, Natalya B. Morozova, Varvara A. Khokhlova, Nadezhda V. Perova, Anna O. Nemechkina

    BACKGROUND: Defects after melanoma resection require effective and minimally invasive methods for their management to be developed. Current techniques have several limitations and do not always provide a satisfactory aesthetic outcome. Thus, new techniques, including gel injection, should be developed. Рeterogeneous collagen-based formulation is one of the promising options. It has shown its effectiveness in enhancement of wound healing; however, there is no data on its interaction with tumor cells. AIM: The study aimed to assess the interaction and effect of heterogeneous collagen-based formulation on B16-F1 melanoma in an experiment. METHODS: The experiment was conducted on laboratory animals (mice) divided into groups to receive injections of heterogeneous collagen-based formulation and 0.9% sodium chloride solution. Laboratory animals were monitored for 20 days, weight and tumor size were measured regularly. The animals were sacrificed, and the primary tumor, lymph nodes, and lungs were sampled for histological examination. RESULTS: An analysis of the growth rate, metastasis to the lymph nodes and lungs revealed no significant difference between the study and control groups. Tumor histology also did not differ; however, the examination found the injected heterogeneous collagen-based formulation in several samples from unoperated animals. CONCLUSION: The B16-F1 melanoma model showed no effect of the heterogeneous collagen-based formulation on primary tumor growth and metastasis. This result suggests that this material is potentially safe, which is an important step in the search and development of new oncological reconstructions techniques.

  • Investigation of the oncological safety of a heterogeneous collagen-containing composition in an experimental model of breast cancer

    by D.V. Davydov, M.O. Karpechkin, N.B. Morozova, V.A. Khokhlova

    Post-resection defects in the treatment of breast cancer require the development of safe and effective methods for their correction. Current approaches are often associated with limitations, which drives further research and the creation of new implantable materials. A heterogeneous collagen-containing composition (HCCC) represents a promising material for improving healing and preventing recurrence; however, its effect on tumor growth dynamics and metastasis remains insufficiently studied. Objective. To assess the impact of HCCC on tumor growth dynamics and the frequency of metastasis in an experimental 4T1 breast cancer model in mice. Methods. The experiment was conducted on mice divided into groups receiving injections of HCCC or saline solution. During the 43-day observation period, the size and mass of tumor nodules, as well as the frequency of metastasis to the lungs and regional lymph nodes, were assessed. Histological analysis of tissues was also performed to evaluate the effect of HCCC on tumor tissue and its microenvironment. Results. In some cases, encapsulation of the material in surrounding tissues was observed in the groups with HCCC administration; however, HCCC was not detected in the groups with surgical intervention on the primary tumor. The frequency and degree of metastasis inhibition did not differ between the experimental and control groups. Statistical analysis revealed no significant differences in tumor growth dynamics and metastasis. Conclusion. The use of HCCC did not have a significant impact on the tumor process or metastasis in this breast cancer model. The results indicate a neutral effect of HCCC, which may be beneficial for further research on biocompatible implantable materials.

  • Tumor models in cancer research

    by M.O. Karpechkin, D.V. Davydov, N.B. Morozova, M.S. Vorontsova

    According to statistics, cancer incidence is coming out on top in the world. Despite the fact that various types of tumors have been known for a relatively long time, currently science is far from a thorough understanding of carcinogenesis, and therefore from a complete cure for tumors. Experiments are constantly being conducted to develop not only new treatment methods, but also medicines. All these experiments are based on tumor models. This article presents the main tumor models used in oncology.

  • Breast cancer: types of implantable materials for replacement of postresection defects

    by M.O. Karpechkin, D.V. Davydov, A.F. Kutsuradis

    Breast cancer occupies a leading position in morbidity and mortality not only in Russia, but also around the world. Despite the outstanding results in the development of surgical techniques, the issue of preventing deformities after tissue removal during breast surgery remains open. To eliminate deformations, various types of transplants were considered: autografts (autologous fat), allografts (alloplant), materials of non-biological origin (polyacrylamide gel, silicone gel) and natural polymers (hyaluronic acid).